Deconstructing pediatric depression trials: An analysis of the effects of expectancy and therapeutic contact

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 50, Issue 8, 2011, Pages 782-795

  Rutherford, Bret R ^a   Sneed, Joel R ^b   Tandler, Jane M ^c   Rindskopf, David ^d   Peterson, Bradley S ^a,c   Roose, Steven P ^a  

^a Box 98 ^*  (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

antidepressant; expectancy; major depressive disorder; placebo effect; randomized controlled trial

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; ESCITALOPRAM; FLUOXETINE; IMIPRAMINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PLACEBO; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ARTICLE; CHILDHOOD DISEASE; COGNITIVE THERAPY; CONFIDENCE INTERVAL; DEPRESSION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DYSTHYMIA; GROUPS BY AGE; HAMILTON SCALE; HUMAN; HUMAN RELATION; INTENTION TO TREAT ANALYSIS; MAJOR DEPRESSION; META ANALYSIS; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; STATISTICAL MODEL; STUDY DESIGN;

ADOLESCENT; AGE FACTORS; ANTIDEPRESSIVE AGENTS; CHILD; CLINICAL TRIALS AS TOPIC; DEPRESSIVE DISORDER; HUMANS; LOGISTIC MODELS; PLACEBO EFFECT; PROFESSIONAL-PATIENT RELATIONS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 79960841137     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1016/j.jaac.2011.04.004     Document Type: Article

References (65)

1. B. Birmaher, D. Brent, and W. Bernet Practice parameter for the assessment and treatment of children and adolescents with depressive disorders J Am Acad Child Adolesc Psychiatry 46 2007 1503 1526
2. A. Angold, E.J. Costello, and A. Erkanli Comorbidity J Child Psychol Psychiatry 40 1999 57 87 (Pubitemid 29051937)
3. B. Birmaher, N.D. Ryan, and D.E. Williamson Childhood and adolescent depression: a review of the past ten years Part I J Am Acad Child Adolesc Psychiatry 35 1996 1427 1439 (Pubitemid 26360928)
4. G.J. Emslie Understanding placebo response in pediatric depression trials Am J Psychiatry 166 2009 1 3
5. D. Cohen, E. Deniau, and A. Maturana Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials PLOS One 7 2008 1 8
6. J.A. Bridge, B. Birmaher, S. Iyengar, R.P. Barbe, and D.A. Brent Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder Am J Psychiatry 166 2009 42 49
7. B.R. Rutherford, T.D. Wager, and S.P. Roose Expectancy effects in the treatment of depression: a review of experimental methodology, effects on patient outcome, and neural mechanisms Curr Rev Psychiatry 6 2010 1 10
8. B.R. Rutherford, J.R. Sneed, and S.P. Roose Does study design affect outcome? The effects of placebo control and treatment duration in antidepressant trials Psychother Psychosom 78 2009 172 181
9. J.R. Sneed, B.R. Rutherford, D. Rindskopf, and S.P. Roose Design makes a difference: antidepressant response rates in placebo-controlled versus comparator trials in late life depression Am J Geriatr Psychiatry 16 2008 65 73
10. B.R. Rutherford, J.R. Sneed, R. Eisenstadt, and S.P. Roose Antidepressant study design affects patient expectancy: a pilot study Psychol Med 40 2010 781 788
11. B. Meyer, P.A. Pilkonis, J.L. Krupnick, M.K. Egan, S.J. Simmens, and S.M. Sotsky Treatment expectancies, patient alliance, and outcome: further analyses from the National Institute of Mental Health Treatment of Depression Collaborative Research Program J Consult Clin Psychol 70 2002 1051 1055 (Pubitemid 34847994)
12. H.V. Krell, A.F. Leuchter, M. Morgan, I.A. Cook, and M. Abrams Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant J Clin Psychiatry 65 2004 1174 1179
13. M. Fava, A.E. Evins, D.J. Dorer, and D.A. Schoenfeld The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach Psychother Psychosom 72 2003 115 127 (Pubitemid 36469860)
14. E.O. Poznanski, S.C. Cook, and B.J. Carroll A depression rating scale for children Pediatrics 64 1979 442 450 (Pubitemid 9247602)
15. E.O. Poznanski, and H.B. Mokros Children's Depression Rating ScaleRevised 1996 Western Psychological Services Los Angeles
16. M. Hamilton A rating scale for depression J Neurol Neurosurg Psychiatry 23 1960 56 62
17. S.A. Montgomery, and M. Asberg A new depression scale designed to be sensitive to change Br J Psychiatry 134 1979 382 389 (Pubitemid 9136500)
18. W. Guy Clinical Global Impressions New Clinical Drug Evaluation Unit (ECDEU) Assessment Manual for Psychopharmacology 1976 National Institute of Mental Health Rockville, MD 218 222
19. J. Puig-Antich, and W. Chambers The Schedule for Affective Disorders and Schizophrenia for School-Age Children (Kiddie-SADS) 1978 New York State Psychiatric Institute New York
20. A.S. Bryk, and S.W. Raudenbush Hierarchical Linear Models 1992 Sage Publications Newbury Park, CA
21. J. Hox Multilevel Analysis: Techniques and Applications 2002 Lawrence Erlbaum Publishers Mahwah, NJ
22. C.K. Haddock, D. Rindskopf, and W.R. Shadish Using odds ratios as effect sizes for meta-analysis of dichotomous data: a primer on methods and issues Psychol Methods 3 1998 339 353
23. R.T. Birge The calculation of errors by the method of least squares Rev Mod Physics 40 1932 207 227
24. J.P.T. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558 (Pubitemid 34746062)
25. G.J. Emslie, R.L. Findling, P.P. Yeung, N.R. Kunz, and Y. Li Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials J Am Acad Child Adolesc Psychiatry 46 2007 479 488 (Pubitemid 46622756)
26. R.L. Findling, S.H. Preskorn, and R.N. Marcus Nefazodone pharmacokinetics in depressed children and adolescents J Am Acad Child Adolesc Psychiatry 39 2000 1008 1016 (Pubitemid 30639792)
27. B. Geller, T.B. Cooper, E.C. Chestnut, J.A. Anker, and M.D. Schluchter Preliminary data on the relationship between nortriptyline plasma level and response in depressed children Am J Psychiatry 143 1986 1283 1286 (Pubitemid 16008716)
28. C.A. Glod, A. Lynch, E. Flynn, C. Berkowitz, and R.J. Baldessarini Open trial of bupropion SR in adolescent major depression J Child Adolesc Psychatr Nurs 16 2003 123 130
29. P.J. Goodnick, C.A. Jorge, T. Hunter, and A.M. Kumar Nefazodone treatment of adolescent depression: an open-label study of response and biochemistry Ann Clin Psychiatry 12 2000 97 100 (Pubitemid 30470155)
30. M.K. Nixon, R. Milin, J.G. Simeon, P. Cloutier, and W. Spenst Sertraline effects in adolescent major depression and dysthymia: a six-month open trial J Child Adolesc Psychopharmacol 11 2001 131 142 (Pubitemid 32588484)
31. M. Nobile, B. Bellotti, C. Marino, M. Molteni, and M. Battaglia An open trial of paroxetine in the treatment of children and adolescents diagnosed with dysthymia J Child Adolesc Psychopharmacol 10 2000 103 109 (Pubitemid 30490917)
32. E. Shirazi, and J. Alaghband-Rad An open trial of citalopram in children and adolescents with depression J Child Adolesc Psychopharmacol 15 2005 233 239 (Pubitemid 40734102)
33. B.D. Waslick, B.T. Walsh, L.L. Greenhill, M. Eilenberg, L. Capasso, and D. Lieber Open trial of fluoxetine in children and adolescents with dysthymic disorder or double depression J Affect Disord 56 1999 227 236 (Pubitemid 30058227)
34. A. Braconnier, R. Coent, and D. Cohen Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial J Am Acad Child Adolesc Psychiatry 42 2003 22 29 (Pubitemid 39610610)
35. G. Clarke, L. Debar, and F. Lynch A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication J Am Acad Child Adolesc Psychiatry 44 2005 888 898 (Pubitemid 41193200)
36. I. Goodyer, B. Dubicka, and P. Wilinson Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomized controlled trial BMJ 332 2007 1 8
37. G.A. Melvin, B.J. Tonge, N.J. King, D. Heyne, M.S. Gordon, and E. Klimheit A comparison of cognitive-behavioral therapy, sertaline, and their combination for adolescent depression J Am Acad Child Adolesc Psychiatry 45 2006 1151 1161 (Pubitemid 44465635)
38. R. Berard, R. Fong, D.J. Carpenter, C. Thomason, and C. Wilkinson An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder J Child Adolesc Psychopharmacol 16 2006 59 75
39. G.J. Emslie, A.J. Rush, and W.A. Weinberg A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression Arch Gen Psychiatry 54 1997 1031 1037 (Pubitemid 27476099)
40. G.J. Emslie, J.H. Heiligenstein, and K.D. Wagner Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial J Am Acad Child Adolesc Psychiatry 41 2002 1205 1215 (Pubitemid 38338040)
41. G.J. Emslie, K.D. Wagner, and S. Kutcher Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial J Am Acad Child Adolesc Psychiatry 45 2006 709 719 (Pubitemid 43833104)
42. G.J. Emslie, P.P. Yeung, and N.R. Kunz Long-term, open-label venlafaxine extended-release treatment in children and adolescents with major depressive disorder CNS Spectr 12 2007 223 233 (Pubitemid 46555891)
43. G.J. Emslie, D. Ventura, A. Korotzer, and S. Tourkodimitris Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial J Am Acad Child Adolesc Psychiatry 48 2009 721 729
44. B. Geller, T.B. Cooper, D.L. Graham, H.H. Fetner, F.A. Marsteller, and J.M. Wells Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder J Am Acad Child Adolesc Psychiatry 31 1992 34 44
45. B. Geller, T.B. Cooper, D.L. Graham, F.A. Marsteller, and D.M. Bryant Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design Psychopharmacol Bull 26 1990 85 90 (Pubitemid 20322251)
46. M.B. Keller, N.D. Ryan, and M. Strober Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial J Am Acad Child Psychiatry 40 2001 762 772 (Pubitemid 32595260)
47. R.G. Klein, S. Mannuzza, and H.S. Koplewicz Adolescent depression: controlled desipramine treatment and atypical features Depress Anxiety 7 1998 15 31 (Pubitemid 28248516)
48. S. Kutcher, C. Boulos, and B. Ward Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial J Am Acad Child Adolesc Psychiatry 33 1994 686 694 (Pubitemid 24167027)
49. C.H. Kye, G.S. Waterman, and N.D. Ryan A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression J Am Acad Child Adolesc Psychiatry 35 1996 1139 1144 (Pubitemid 26282594)
50. J. Puig-Antich, J.M. Perel, and W. Lupatkin Imipramine in prepubertal major depressive disorders Arch Gen Psychiatry 44 1987 81 89 (Pubitemid 17210496)
51. Treatment for Adolescents with Depression Study Team Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial JAMA 292 2004 807 820
52. A.L. Von Knorring, G.I. Olsson, P.H. Thomsen, O.M. Lemming, and A. Hulten A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder J Clin Psychopharmacol 26 2006 311 315 (Pubitemid 43804624)
53. K.D. Wagner, P. Ambrosini, and M. Rynn Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials JAMA 290 2003 1033 1041 (Pubitemid 37430443)
54. K.D. Wagner, A.S. Robb, R.L. Findling, J. Jin, M.M. Gutierrez, and W.E. Heydorn A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents Am J Psychiatry 161 2004 1079 1083 (Pubitemid 38735994)
55. K.D. Wagner, J. Jonas, R.L. Findling, D. Ventura, and K. Saikali A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression J Am Acad Child Adolesc Psychiatry 45 2006 280 288
56. B.R. Rutherford, S. Rose, J.R. Sneed, and S.P. Roose Study design affects participant expectations: a survey J Clin Psychopharmacol 29 2009 179 181
57. D. Cohen, E. Deniau, and A. Maturana Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials PLOS One 7 2008 1 8
58. S. Shirk, G. Gudmundsen, and H. Kaplinski Alliance and outcome in cognitive-behavioral therapy for adolescent depression J Clin Child Adolesc Psychol 37 2008 631 639
59. R. DiGiuseppe, J. Linscott, and R. Jilton Developing the therapeutic alliance in child-adolescent psychotherapy Appl Prev Psychol 5 1996 85 100
60. M. Trivedi, and J. Rush Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications? Neuropsychopharmacology 11 1995 33 43 (Pubitemid 24277736)
61. S.M. Marcus, J.M. Gorman, and X. Tu Rater bias in a blinded randomized placebo-controlled psychiatry trial Stat Med 25 2006 2762 2770 (Pubitemid 44193382)
62. J.A. Bridge, A. Iyengar, and C.B. Salary Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials JAMA 297 2007 1683 1696
63. R. Tao, G. Emslie, T. Mayes, P. Nakonezny, B. Kennard, and C. Hughes Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder J Am Acad Child Adolesc Psychiatry 48 2009 71 78
64. R.A. Kowatch, T.J. Carmody, G.J. Emslie, J.W. Rintelmann, C.W. Hughes, and A.J. Rush Prediction of response to fluoxetine and placebo in children and adolescents with major depression: a hypothesis generating study J Affect Disord 54 1999 269 276 (Pubitemid 29329435)
65. J. Curry, P. Rohde, and A. Simons Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS) J Am Acad Child Adolesc Psychiatry 45 2006 1427 1439 (Pubitemid 44900916)